Xijing Hospital

This study tests whether removing the central mole (nevus) along with standard medication works better than medication alone for people with halo nevus and vitiligo. Sixty participants aged 6 to 45 will be randomly assigned to one of two groups and followed for 6 months. The goal…

This study tests whether exosomes from umbilical cord stem cells can safely help restore skin color in adults with vitiligo. It includes 96 people with active or stable vitiligo, comparing the exosome treatment plus standard therapy to standard therapy alone. The goal is to see i…

This study tests whether giving two drugs—Serplulimab and trastuzumab rezetecan—before surgery can eliminate all signs of triple-negative breast cancer in 84 women. The goal is to see if this approach leads to a complete response (no cancer left in the breast or lymph nodes). Par…

This study tests a new drug called zanidatamab combined with chemotherapy before surgery for people with a specific type of stomach or gastroesophageal junction cancer that has high levels of HER2. About 30 adults with stage II or III cancer will receive the treatment to see if i…

This study tests a combination of three drugs (neratinib, fulvestrant, and eribulin) in 35 women with a specific type of advanced breast cancer (HR+/HER2+) that has stopped responding to the drug trastuzumab deruxtecan. The goal is to see if this new mix can shrink tumors or slow…

This study tests two different medications given at the end of colorectal surgery to reverse muscle relaxants. The goal is to see which one helps the bowel start working again sooner, reducing nausea, vomiting, and hospital stay. About 560 adults having planned colorectal surgery…

This study tests a new pain medicine, oliceridine fumarate, in 428 adults having lumbar spine surgery. The goal is to see if it controls pain as well as standard opioids but helps the gut recover faster (eating solid food and passing gas). Participants will be randomly assigned t…

This study tests a safe, non-invasive treatment for people with disorders of consciousness after severe brain injury. It uses mild electrical pulses on specific hand acupoints (TEAS) for 14 days. The goal is to see if this can help improve awareness and responsiveness compared to…

This study tests a new, non-invasive brain stimulation method called temporal interference (TI) to reduce seizures in people with drug-resistant temporal lobe epilepsy. Thirty adults aged 18-65 who have at least two seizures per month despite taking two or more anti-epileptic dru…

This study watches how the brain heals in the first week after a stroke clot is removed. Researchers will monitor 180 adults to see if early brain activity patterns can predict recovery at 90 days. The goal is to create a tool that helps doctors personalize rehabilitation.

This study looks at whether giving tube feedings in short bursts (intermittent) is better than a steady drip (continuous) for people with severe stroke. About 60 patients will be randomly assigned to one method, and researchers will track survival, brain recovery, nutrition level…

This study looks at whether the way you sleep before heart surgery is connected to your risk of confusion (delirium) and kidney injury after the operation. Researchers will track 549 adults having planned heart surgery with a heart-lung machine. The goal is to better understand t…

This study aims to create a model using a panel of 12 immune-signaling proteins (cytokines) in the blood to predict whether vitiligo will worsen or improve with treatment. Researchers will enroll 125 adults with vitiligo and a healthy comparison group. The goal is to find objecti…

This study looks at whether using a blue dye alone to find and remove key lymph nodes after chemotherapy is safe and effective for women with breast cancer that had spread to the armpit. About 240 women will get the dye-guided biopsy plus standard lymph node removal. The goal is …

This study follows 1,630 people with a very small, low-risk thyroid cancer to see how three different strategies—surgery, heat ablation, or simply monitoring—affect safety and quality of life over 10 years. Participants choose their treatment with their doctor. The goal is to fin…